Table 1 Clinical characteristics of 19 TFE3-positive RCCs.
From: Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma
| Â | Value |
|---|---|
Median age at diagnosis, year (IQR) | 45 (40–52) |
Female, n (%) | 11 (57.9) |
Diabetes, n (%) | 1 (5.3) |
Hypertension, n (%) | 3 (15.8) |
BMI, kg/m2 (IQR) | 21.6 (20.7–23.2) |
Tumor location, n (%) | |
Right | 11 (57.9) |
Left | 8 (42.1) |
Pathological T stage, n (%) | |
T 1/2 | 11 (57.9) |
T 3/4 | 8 (42.1) |
Node positive, n (%) | 5 (26.3) |
Distant metastasis, n (%) | 4 (21.1) |
Operation methods, n (%) | |
Radical nephrectomy | 12 (63.2) |
Partial nephrectomy | 7 (36.8) |
Laparoscopic approach, n (%) | 5 (26.3) |
Tumor size, cm (IQR) | 5.0 (3.3–6.7) |
Fuhrman nuclear grade, n (%) | |
1/2 | 1 (5.3) |
3 | 14 (73.7) |
4 | 4 (21.1) |
Presence of lympho-vascular invasion, n (%) | 5 (26.3) |
Positive surgical margin, n (%) | 2 (10.5) |
Recurrence, n (%) | 4 (21.1) |
Recurrence free survival, mo (IQR) | 31 (24–54) |
Deceased, n (%) | 3 (15.8) |
